The Scleroderma Foundation is pleased to announce that we have
demonstrated a commitment to transparency by being awarded Gold Participant
status on Guidestar. A
national charity that ranks
nonprofits, Guidestar provides current and
comprehensive information to potentials donors.
Guidestar is generally regarded as the preeminent online destination of
donors when researching nonprofits.
Scholarship Deadline Fast Approaching
The foundation's National Patient Education Conference brings hope to those who may feel alone in the fight against scleroderma. Thanks to the generous support of many donors and chapters, conference scholarships are now available to the 2017 National Patient Education Conference to be held in Chandler, Arizona from July 21-23. It's important to note that scholarships not only cover registration costs but can be used to offset hotel and travel costs. Be sure to apply today as the deadline is March 16!
Gastroparesis, also called delayed gastric emptying, is a disorder that slows or stops the movement of food from the stomach to the small intestine. Normally, the muscles of the stomach, which are controlled by the vagus nerve, contract to break up food and move it through the gastrointestinal (GI) tract.
As a fellow in 2006, Tim Lahm, M.D. — now director of pulmonary research and co-director of the Pulmonary Hypertension Program at the Indiana University School of Medicine — proposed what he considered to be a credible research project. Knowing that some forms of pulmonary hypertension (PH) are found more often in women than men, his idea was to focus on the differences between genders with regard to the development of WHO Group 1 PH (PAH, pulmonary arterial hypertension).
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
The Scleroderma Foundation is a qualified national nonprofit operating under 501(c)(3) status. The foundation’s federal tax identification number is 52-1375827. Our primary goal is to raise funds for our three-fold mission of support, education and research. The foundation has 20 active chapters and 160 support groups across the country.